Free Trial

Solid Biosciences (SLDB) News Today

Solid Biosciences logo
$5.62 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$5.62 0.00 (-0.09%)
As of 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SLDB Latest News

Solid Biosciences to Participate at Upcoming Investor Conferences
Q3 EPS Forecast for Solid Biosciences Increased by Analyst
Leerink Partnrs Weighs in on SLDB Q1 Earnings
HC Wainwright Brokers Reduce Earnings Estimates for SLDB
Konskie, Poland - December 14, 2024: Sarepta Therapeutics company logo displayed on mobile phone — Stock Editorial Photography
Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside (SLDB)
Per two Wall Street analysts, one of 2025's biggest losers could be set up for a stunning recovery. They see over 175% upside in Sarepta Therapeutics.
Solid Bio Green on Fast Track Nod
SLDB - Solid Biosciences Inc Executives - Morningstar
SLDB Solid Biosciences Inc. - Seeking Alpha
Solid Biosciences Inc. (SLDB) - Yahoo Finance
SLDB - Solid Biosciences Inc Valuation - Morningstar
Solid Biosciences Inc. (SLDB) Cash Flow - Yahoo Finance
Get Solid Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SLDB Media Mentions By Week

SLDB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SLDB
News Sentiment

1.63

0.99

Average
Medical
News Sentiment

SLDB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SLDB Articles
This Week

4

4

SLDB Articles
Average Week

Get the Latest News and Ratings for SLDB and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Solid Biosciences and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:SLDB) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners